XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Investments, cost $ 1,975,630 [1] $ 1,803,609 [2]
Deferred financing costs, net $ 10,643 $ 6,178
Common stock par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 54,184,636 55,299,484
Common stock, shares outstanding (in shares) [3] 54,184,636 55,299,484
Non-controlled, non-affiliated investments    
Investments, cost $ 1,610,822 $ 1,580,844
Non-controlled, affiliated investments    
Investments, cost 210,103 140,344
Controlled investments    
Investments, cost $ 154,705 $ 82,421
[1] Represents amortized cost for debt securities and cost for equity investments.
[2] Represents amortized cost for debt securities and cost for equity investments.
[3] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share for 2021 reflect the reverse stock split on a retroactive basis.